Company Overview
AI platform to authenticate medicines & a platform to enable pharmacy procurement
Company History
RxAll was founded in 2016. Public founder information in the source set points to Adebayo Alonge, Amy Kao. Its latest captured funding/news event in the source set was in 2025, recorded as Grant.
Key Facts
| Country | Nigeria |
| Founded | 2016 |
| Founders | Adebayo Alonge, Amy Kao |
| Sector | Healthcare |
| Operational Status | Appears active |
| Latest Round | Grant, 2025, $0.23M |
| Total Disclosed Funding | $3.48M |
| Website | https://www.rxall.net/ |
Business Model
RxAll appears to operate a product-led business model in the Healthcare sector. Based on public descriptions, it generates value through technology-enabled services, software, marketplace access, operations, or financial infrastructure.
Products and Services
- Pharmaceutical or care infrastructure
- Hospital or provider digitisation
- Supply-chain services
- Patient access tools
Funding and Market Position
Public deal records in the source set show 3 disclosed funding event(s), with about $3.48M captured in total. The most recent event is recorded as Grant, 2025, $0.23M.
Contact Information
The most reliable public contact channel in the source set is the official website: https://www.rxall.net/. Public phone numbers and public support emails were not consistently available at scale, so the website/contact form is the best public route.
Company Location
Operational Status
Latest public funding/news source in 2025 suggests the startup was operating at that time. Status recorded here is a best-effort assessment as of March 21, 2026.
Why This Startup Matters
As a Nigerian startup in the Healthcare space, RxAll matters because it addresses local market problems with a scalable digital product or operational model.
Sources
Related Startups
- Platos Health
- Myltura
- Sproxil